Dr. Jorg Tost

Centre National de Recherche en Genomique Humaine

Unlocking the potential of epigenomics: Pioneering research in oncology and personalized medicine

Epigenomics plays a crucial role in oncology by unraveling the intricate molecular modifications that influence gene expression patterns and provide valuable insights into cancer development, progression, and potential therapeutic targets. In this video, Dr. Jorg Tost, Head, Laboratory for Epigenetics & Environment at CEA – IBFJ, discusses his work identifying epigenetic changes that can be used for the next generation of personalized medicine including in immune-oncology applications. Prof. Martin Hirst, Professor and Director, Michael Smith Laboratories, The University of British Columbia, also describes his research which is focused on developing our understanding of epigenomics further through his work at the International Human Epigenome Consortium (IHEC).



LIKE 1
Dr. Jorg Tost
Precision Medicine Cancer Research Digital oncology

Dr. Jorg Tost

Biography

Dr. Jorg Tost, Head, Laboratory for Epigenetics & Environment at CEA - IBFJ, Centre National de Recherche en Genomique Humaine (CNG) More

Dr. Jorg Tost

Centre National de Recherche en Genomique Humaine

Dr. Jorg Tost received his Ph.D. in epigenetics/genetics from the Saarland University (Germany) in 2004 devising novel methods for the elucidation of gene function and regulation. After a postdoctoral position at the Centre National de Génotypage (CNG, Evry, France), he led the Epigenetics groups from 2006-2012, before becoming Head of the Laboratory for Epigenetics and Environment at the Centre National de Génotypage.